ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Feng Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2034-6351; OpenAlex author ID A5125135807. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2026: 2 papers

Papers 2

c-Myc/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation. Co-author DOI 10.1038/s41419-026-08439-0 ↗
Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer. Co-author DOI 10.1038/s41467-026-73871-x ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wei Cui · 2 shared papers, 2026 · strength 0.53
- Paper c-Myc/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation. DOI 10.1038/s41419-026-08439-0 ↗
- Paper Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic tar… DOI 10.1038/s41467-026-73871-x ↗
Hezhi Fang · 2 shared papers, 2026 · strength 0.53
- Paper c-Myc/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation. DOI 10.1038/s41419-026-08439-0 ↗
- Paper Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic tar… DOI 10.1038/s41467-026-73871-x ↗
Jing Wang · 1 shared paper, 2026 · strength 0.28
- Paper c-Myc/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation. DOI 10.1038/s41419-026-08439-0 ↗
Tao Huang · 1 shared paper, 2026 · strength 0.28
- Paper c-Myc/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation. DOI 10.1038/s41419-026-08439-0 ↗
Kai Lin · 1 shared paper, 2026 · strength 0.25
- Paper Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic tar… DOI 10.1038/s41467-026-73871-x ↗
Ruijun Tian · 1 shared paper, 2026 · strength 0.25
- Paper Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic tar… DOI 10.1038/s41467-026-73871-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.